Crestchem Limited has fixed Thursday, July 31, 2026, as the record date to determine member entitlement for the final dividend for the financial year ended March 31, 2026. The 34th Annual General Meeting (AGM) of the company is scheduled to be held on Thursday, August 6, 2026, at 12:15 P.M. (IST) through Video Conferencing (VC) or Other Audio Visual Means (OAVM). The Register of Members and Share Transfer Books will remain closed from Wednesday, July 31, 2026, to Tuesday, August 6, 2026, for the purpose of the AGM.

Pursuant to the provisions of the Companies Act, 2013, and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has appointed M/s. Rahul Mevada & Associates as the Scrutinizer to scrutinize the e-voting process. The facility for remote e-voting will be provided by Central Depository Services (India) Limited (CDSL). Shareholders holding shares in physical or dematerialized form as on the cut-off date of Thursday, July 31, 2026, will be eligible to cast their votes electronically.

Key Meeting Dates

The final dividend, if declared at the AGM, is proposed to be paid on and from Wednesday, August 12, 2026. Members who have not provided their bank details for electronic credit will receive dividend warrants or banker's cheques at their registered addresses. The Annual Report for FY 2025-26 has been sent via email to members registered with the company, its Registrar and Transfer Agent (RTA), or depositories.

Crestchem Limited reported a net profit of ₹2.71 crore for the financial year ended March 31, 2026, compared to ₹2.73 crore in the previous year. The company's total income rose to ₹25.52 crore from ₹21.52 crore in FY25. The board has recommended a final dividend of ₹1.50 per share for the year.

The board of directors has approved the audited standalone and consolidated financial statements for the year ended March 31, 2026. The company's earnings per share (EPS) stood at ₹9.04 for FY26, down from ₹9.08 in the previous year.

Financial Performance

The company's financial performance for the year under review is summarized below:

*Each share having face value of ₹10/

Dividend Declaration

The board has recommended a final dividend of ₹1.50 (15%) per equity share of ₹10 each for the financial year ended March 31, 2026. The dividend is subject to the approval of shareholders at the ensuing annual general meeting.

Subsidiary and Expansion

During the year, the company incorporated Oleo Biosciences Private Limited as a wholly owned subsidiary with 75% shareholding. The subsidiary has been established to manufacture Medium Chain Triglyceride (MCT) Oil. Commercial production at the subsidiary is expected to commence during the fourth quarter of the financial year 2026-27.

The board believes that this project will diversify the company's business portfolio and strengthen its long-term growth prospects. The procurement and installation of plant and machinery for the project are currently in progress.